Skip to content
FIND A BIOALPS ACTOR

Actor

Calliditas Therapeutics Suisse SA (former GenKyoTex SA)

Share this actor

Leading biopharmaceutical company developing NOX therapies. Its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration

Specialties

Primary Therapeutic Areas

1.0 Therapeutic & Diagnostic

1.10 Small Molecules

Business model

1. Entreprise

1.5 Multinational

Organization Type

Private Company


Visit website

Domains

Cardiovascular & Hematology, Endocrine & Metabolic, Neurology, Oncology

Main sector

Biotech

Contact

Chemin des Aulx 16
1228 Plan-les-Ouates / GE
022 880 10 25

businessdevelopment@calliditas.com